Research Status and Progress of Third-generation EGFR-TKIs 
in Elderly Patients with Non-small Cell Lung Cancer

Research Status and Progress of Third-generation EGFR-TKIs 
in Elderly Patients with Non-small Cell Lung Cancer

For patients with advanced non-small cell lung cancer (NSCLC) harboring sensitive epidermal growth factor receptor (EGFR) mutations, guidelines prioritize the use of third-generation EGFR-tyrosine kinase inhibitors (EGFR-TKIs), which offer higher objective response rate (ORR), longer progression-fre...

Full description

Saved in:
Bibliographic Details
Main Authors: Xue CHEN, Yijia SUN, Lihong ZHANG, Bo JIANG
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2025-05-01
Series:Chinese Journal of Lung Cancer
Subjects:
lung neoplasms
epidermal growth factor receptor-tyrosine kinase inhibitors
research status
research progress
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2025.101.09
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2025.101.09

Similar Items